Relation of Inflammation and Benefit of Statins After Percutaneous Coronary Interventions

Abstract

Statin therapy before PCI is associated with a marked reduction in mortality among patients with high hsCRP levels. A hsCRP-guided strategy may improve targeting of statin therapy and clinical outcome among patients undergoing PCI.